Changzhou Qianhong Biopharma Co Ltd Strategic Asset Allocation Index
Changzhou Qianhong Biopharma Co Ltd strategic asset allocation index. Changzhou Qianhong Biopharma Co Ltd (002550) has a Strategic Asset Allocation Index of 22.7% as of September 2023. Strategic assets (PP&E of CN¥562.19 Million plus long-term investments of CN¥-) total CN¥562.19 Million, measured against net assets of CN¥2.48 Billion. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. See debt-free asset ratio of Changzhou Qianhong Biopharma Co Ltd to measure how much of total assets are equity-financed.
SAAI
Strategic Assets
PP&E
Net Assets
Strategic Asset Allocation Index of Changzhou Qianhong Biopharma Co Ltd (2007–2021)
Strategic asset allocation index of Changzhou Qianhong Biopharma Co Ltd from 2007 to 2021. This chart shows how Changzhou Qianhong Biopharma Co Ltd's Strategic Asset Allocation Index has evolved across 15 annual periods from 2007 to 2021. As of September 2023, the index stands at 22.7%, representing strategic assets of CN¥562.19 Million against net assets of CN¥2.48 Billion CNY. Check Changzhou Qianhong Biopharma Co Ltd tangible equity quality to evaluate the tangible quality of the company's equity base.
Changzhou Qianhong Biopharma Co Ltd Strategic Asset Allocation Index by Year (2007–2021)
Changzhou Qianhong Biopharma Co Ltd strategic asset allocation index by year from 2007 to 2021. The table below presents the year-by-year Strategic Asset Allocation Index for Changzhou Qianhong Biopharma Co Ltd from 2007 to 2021, covering 15 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see Changzhou Qianhong Biopharma Co Ltd market cap and net worth.
| Year | SAAI | Strategic Assets (CNY) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2021 | 28.9% | CN¥611.77 Million | CN¥611.77 Million | CN¥- | CN¥2.12 Billion | ▼ -0.1 pp |
| 2020 | 29.0% | CN¥599.56 Million | CN¥599.56 Million | CN¥- | CN¥2.07 Billion | ▲ +2.6 pp |
| 2019 | 26.5% | CN¥617.20 Million | CN¥617.20 Million | CN¥- | CN¥2.33 Billion | ▲ +2.6 pp |
| 2018 | 23.9% | CN¥605.79 Million | CN¥605.79 Million | CN¥- | CN¥2.54 Billion | ▼ -1.7 pp |
| 2017 | 25.6% | CN¥627.61 Million | CN¥627.61 Million | CN¥- | CN¥2.45 Billion | ▼ -16.5 pp |
| 2016 | 42.1% | CN¥1.02 Billion | CN¥657.79 Million | CN¥361.81 Million | CN¥2.42 Billion | ▲ +18.1 pp |
| 2015 | 24.0% | CN¥550.08 Million | CN¥550.08 Million | CN¥- | CN¥2.29 Billion | ▲ +9.4 pp |
| 2014 | 14.6% | CN¥311.47 Million | CN¥311.47 Million | CN¥- | CN¥2.13 Billion | ▲ +1.0 pp |
| 2013 | 13.6% | CN¥268.22 Million | CN¥268.22 Million | CN¥- | CN¥1.97 Billion | ▲ +6.5 pp |
| 2012 | 7.1% | CN¥133.59 Million | CN¥133.59 Million | CN¥- | CN¥1.87 Billion | ▲ +1.1 pp |
| 2011 | 6.1% | CN¥107.38 Million | CN¥107.38 Million | CN¥- | CN¥1.77 Billion | ▼ -15.7 pp |
| 2010 | 21.8% | CN¥90.31 Million | CN¥90.31 Million | CN¥- | CN¥413.78 Million | ▼ -11.9 pp |
| 2009 | 33.7% | CN¥82.19 Million | CN¥82.19 Million | CN¥- | CN¥243.68 Million | ▼ -4.8 pp |
| 2008 | 38.5% | CN¥83.89 Million | CN¥83.89 Million | CN¥- | CN¥217.99 Million | ▼ -1.8 pp |
| 2007 | 40.3% | CN¥85.20 Million | CN¥85.20 Million | CN¥- | CN¥211.61 Million | — |